You're killing me. Squires is the only person who can file

New Post Public Reply Private Reply Replies (4) Message Board
JayDee Puravida19 #20957
613
You're killing me. Squires is the only person who can file the S-1? The guy who has a 100% failure rate when it comes to meeting SEC filing requirements? He's not a scientist, he's not an accountant, has not a manager, other than a certain je n' sais quas perceived by only you and rod man, what is it that he brings to the table? You seem to be saying that his primary tangible value is that he has screwed up QTMM so badly that hes the only one who could possibly locate the data necessary to submit to the SEC. It's not in the files, its not written down anywhere.

Has it ever occurred to you that the data for a company that has produced no product and realized zero income cannot possibly be too complicated? And it's made even simpler, at least in your eyes, by the fact that, in your opinion, much of the information does not need to be submitted because it's covered by NDAs.

I think even snark would be able to provide an accurate accounting of sales numbers for 2020. It would require almost no research. The answer is zero. The biggest difficulty, for him, anyway, would be admitting it.

The numbers would be the same for 2019.

So, its really only a matter of expenses. Even if Squires hasn't kept records, there are bank accounts. Expenses could be reconstructed pretty easily. I've seen it done dozens of times by firms that actually turn a profit.

Don't you guys ever think through the assumptions that underlie your rhetoric? What could be so complicated about the last three years of data for a business that produced no product during that period and realized no income?

The problem isn't marshalling the data, and it isn't assembling it into a presentable form. The task that Squires finds so impossible is making the story told by this data consistent with the stories Squires has been telling.

Thats why he needs to blame the mysterious auditors and their impossible and incomprehensible requirements (that every other company doesnt seem to have a problem understanding and meeting).

Considering the simplicity of the task, and, that simplicity notwithstanding, Squires 100% failure rate, saying Squires is the only person who can get the S-1 filed is like saying the only quarterback you would call on to win a Superbowl game is Fran Tarkenton. The only sitter you would trust to watch your son is Kevin Spacey. The only act with chops worthy of headlining the Super Bowl Half Time Show is Milli Vanilli.

When you actually think about it, even you have to concede it's not the complexity of the facts that has prevented the filing, it's the implication of the story told by those facts. It's that the disclosure of these facts will show somebody's been either lying, stealing, or grossly incompetent.

So, you were one word away from being right. Squires isn't the only person who can do it, but hes apparently the only person who can't.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 65

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Lululemon Faces Lawsuit Over Alleged Fraudulent Reporting

Updated Category News Views 110

What's Stirring the Pot for Lululemon? Talk about a rollercoaster. Over here, Lululemon (NASDAQ:LULU) is navigating turbulent waters, facing a class action lawsuit for alleged securities fraud. Investors who bought into the brand between March 18, 2026, and September 3, 2026, are now watching their investments drop, following what's claimed as misleading trumpet calls...

Continue Reading
Greenberg Traurig's Stars Shine in Delaware's Legal Scene

Updated Category News Views 56

Five Lawyers, One Prestigious List Eating lunch today, I nearly dropped my sandwich when I read that five top-notch attorneys from Greenberg Traurig have snagged spots on Delaware Today's 2026 Top Lawyers List. This isn't your everyday pat on the back; it's Delaware, the heavyweight champ of corporate law, after all. The Legal Eagles of Greenberg Traurig Kicking off this...

Continue Reading
Samsung Ups Stake in TCL CSOT: A Game-Changer?

Updated Category News Views 137

Samsung Electronics' Strategic Play Sometimes it takes a gutsy move to shake up the industry, and Samsung Electronics just went for it. Snagging a 10.16% stake in TCL CSOT isn't just some run-of-the-mill acquisition. It's a calculated chess piece placement in the cutthroat display tech arena. Unpacking the Stake Game This latest move shifts Samsung Display's stake to...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
LULU Under Fire: Class Action Opportunities Await

Updated Category News Views 138

Lululemon Faces a Legal Storm If you're holding shares in Lululemon (NASDAQ: LULU), you might want to sit up and pay attention. Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, is gathering folks for a securities fraud class action lawsuit against Lululemon. They're pointing fingers at the company for cooking the books – or at least not being...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 20

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
Sectra Powers Radiology at Mount Sinai with AI Integration

Updated Category News Views 97

AI and Radiology: A Match Made for Mount Sinai Today, we're diving into a technological leap that promises to shake up the healthcare sector—Sectra's integration of artificial intelligence with radiology at Mount Sinai Health System. The deal pairs Sectra's prowess in medical imaging IT and cybersecurity with the healthcare giant in New York, aiming to redefine how...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 32

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 191

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading

Top 5 Most Recently Viewed Articles

Medicenna Reveals Promising MDNA11 Results at SITC Meeting

Updated Category News Views 197

Medicenna's Groundbreaking MDNA11 Updates Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, recently made headlines at a prominent annual meeting dedicated to cancer research. Their innovative approach using MDNA11, a long-acting interleukin-2 super-agonist, is showing significant promise, particularly in the context of advanced solid tumors that have...

Continue Reading
Melco Resorts Restructures Operations for Future Growth

Updated Category News Views 267

Melco Resorts Announces Strategic Changes to Casino Operations Recent developments from Melco Resorts & Entertainment Limited (Nasdaq: MLCO) signal a significant shift in the company's operational strategy. The company, known for its luxurious integrated resort facilities across Asia and Europe, has made the difficult decision to cease operations at the Grand Dragon...

Continue Reading
Verizon Highlights Surge in Cyber Threats in Latest Report

Updated Category News Views 489

Insights from Verizon's 2025 Data Breach Investigations Report In a pivotal revelation, Verizon Business has issued its latest Data Breach Investigations Report, shedding light on an unsettling surge in system intrusions affecting organizations across the Asia-Pacific region. The report emphasizes that a staggering 80% of reported data breaches can be traced back to these...

Continue Reading
BrookBridge Wealth Transitions to LPL Private Wealth Management

Updated Category News Views 109

BrookBridge Private Wealth Joins LPL Financial BrookBridge Private Wealth has officially joined LPL Financial, a move designed to deepen client service and widen what the firm can offer. By aligning with LPL, the team can focus on high-net-worth clients while keeping the personalized, one-to-one approach that defines their work. The transition gives them room to tailor...

Continue Reading
Breckenridge Expands Product Line with Everolimus Approval

Updated Category News Views 225

Breckenridge Announces FDA Approval for Everolimus Tablets In an impressive stride towards enhancing healthcare accessibility, Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International, recently revealed the final FDA approval for Everolimus Tablets for Oral Suspension (TFOS). This generic medication, available in 2mg, 3mg, and 5mg doses, serves as a...

Continue Reading